Investor Relations
The investor pages that follow are your resource for financial information about Achillion Pharmaceuticals. In this section you will find information about our current and historical share price, analyst coverage, SEC filings, an electronic version of our annual report and frequently asked questions as well as forms to request additional information.
Feb 16, 2012
Virology Profile Following Treatment With ACH-1625 Discussed in Oral Presentation at 2012 Asian Pacific Liver Conference
Feb 8, 2012
Achillion to Present at Three Upcoming Investor Conferences
View all »Events & Presentations
Feb 27, 2012
Citi 2012 Global Health Care Conference
|